- $99.43bn
- $118.21bn
- £31.38bn
- 92
- 66
- 99
- 98
REG - Vesuvius plc - Directorate Change
AnnouncementREG - GlaxoSmithKline PLC - GSK publishes provisional 2021 dividend dates
AnnouncementREG - GlaxoSK Capital PLC - EMTN Supplementary Prospectus
AnnouncementREG - GlaxoSmithKline PLC - EMTN Supplementary Prospectus
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Block listing Interim Review
AnnouncementREG - GlaxoSmithKline PLC - Holding(s) in Company
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - Jupiter Asset Mgmnt - Portfolio Update
AnnouncementREG - GlaxoSmithKline PLC - Medicago GSK phase 2/3 study start
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - ViiV’s cabotegravir superior for HIV prevention
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - GSK sets new environmental goals
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
Announcement